` TFX (Teleflex Inc) vs S&P 500 Comparison - Alpha Spread

TFX
vs
S&P 500

Over the past 12 months, TFX has underperformed S&P 500, delivering a return of -49% compared to the S&P 500's +13% growth.

Stocks Performance
TFX vs S&P 500

Loading
TFX
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
TFX vs S&P 500

Loading
TFX
S&P 500
Difference
www.alphaspread.com

Performance By Year
TFX vs S&P 500

Loading
TFX
S&P 500
Add Stock

Competitors Performance
Teleflex Inc vs Peers

Teleflex Inc
Glance View

In the world of medical technology, Teleflex Inc. emerges as a nuanced, multifaceted player, crafting a narrative not just of survival, but of steady growth through innovation and strategic vision. Founded in the allure of post-war optimism in 1943, Teleflex began its journey in the aerospace and marine industries. However, recognizing the steadily aging global population and increasing healthcare demands, the company pivoted towards the medical sector, a decision that has since defined its contemporary identity. Teleflex now thrives as a diversified global provider of medical technologies designed to improve health and the quality of people's lives. It specializes in critical care and surgical solutions, focusing its efforts on areas like vascular access, anesthesia, respiratory care, and urology, among others. Teleflex Inc. crafts its financial landscape through a robust combination of product innovation, strategic acquisitions, and a strong global footprint. Their revenue streams are primarily derived from selling medical devices and equipment to healthcare providers worldwide. A significant competitive edge lies in its ability to consistently introduce new products that address unmet clinical needs while enhancing patient safety and outcomes. This focus is evident in their Research and Development initiatives, which are integral to maintaining their market position. Moreover, by acquiring companies with complementary technologies and market reach, Teleflex continually broadens its portfolio, navigating the complex and evolving healthcare landscape with finesse and agility. Through these strategic maneuvers, the company ensures a steady flow of revenue that aligns with global healthcare trends and demands.

TFX Intrinsic Value
251.4 USD
Undervaluation 55%
Intrinsic Value
Price
Back to Top